BCHS 3305
Fall 2009 Exam
#4 (Answers at
end) 12/02/09
Multiple-Choice. Choose one answer for each question. Each correct answer gets two points. Each wrong answer or no answer gets zero
point but no extra penalty.
On the answer sheet, identify (a) your name AND (b) the last four digits of your UH student #.
· Adenosine is a structural
component of (#1) _____.
[(A) tetrahydrofolate; (B) pyridoxal phosphate; (C) FMN; (D) FAD]
· The IMP synthetic pathway requires 11 enzymes: (1) ribose phosphate pyrophosphokinase, (2) amidophosphoribosyl transferase, (3) glycinamide ribotide synthetase, (4) glycinamide ribotide transformylase, (5) formylglycinamidine
ribotide synthetase, (6)
5-aminoimidazole ribotide synthetase, (7)
5-aminoimidazole ribotide carboxylase, (8)
5-aminoimidazole-4-(N-succinylocarboxamide) ribotide synthetase, (9) adenylosuccinate lyase, (10) 5-aminoimidazole-4-carboxamide
robitide transformylase, and (11)
inosine monophosphate cyclohydrolase.
o For these 11 enzymes, (#2) ____
of them require ATP as a substrate.
[(A)
4; (B) 5; (C) 6; (D) 7; (E) 8]
o For these ATP-requiring enzymes,
(#3) ____ of them produce(s) ADP as one of the products.
[(A)
2; (B) 3; (C) 4; (D) 5; (E) 6]
o For these 11 enzymes, (#4) ____ of them require(s) N5-Formyl-THF
as a substrate.
[(A)
none; (B) 1; (C) 2; (D) 3; (E) 4]
o For these 11 enzymes, (#5) ____
of them require an amino acid as a substrate.
[(A)
2; (B) 3; (C) 4; (D) 5; (E) 6]
· Ribose phosphate
pyrophosphokinase is inhibited by (#6) ____.
[(A) AMP but not ADP or ATP; (B)
ADP but not AMP or ATP; (C) ATP but
not AMP or ADP; (D) AMP, ADP, and
ATP]
· Amidophosphoribosyl transferase
is inhibited by (#7) ____.
[(A) AMP but not ADP or ATP; (B)
ADP but not AMP or ATP; (C) ATP but
not AMP or ADP; (D) AMP, ADP, and
ATP]
· In purine, the N at position 7 is
derived from the (#8) ____, and the N at position 3 is derived from the (#9)
____.
[(A) amine group of glycine; (B) amine group of aspartate; (C) amine group of glutamine, (D) amide group of glutamine]
· The synthesis of AMP from IMP requires
(A) adenylosuccinate synthetase and
(B) adenylosuccinate lyase whereas
the formation of GMP from IMP involves (C)
IMP dehydrogenase and (D) GMP synthetase.
o
ATP
is required as substrate by the enzyme (#10) _____.
o
AMP
is a feedback inhibitor against the enzyme (#11) _____.
· For purine bio-degradations,
(#12) ____.
[(A) AMP can be converted to IMP but adenosine cannot be converted to
inosine; (B) adenosine can be
converted to inosine but AMP cannot be converted to IMP; (C) neither AMP can be converted to IMP nor adenosine can be
converted to inosine; (D) AMP can be
converted to IMP and adenosine can be converted to inosine]
· For purine bio-degradations,
(#13) ____ is a product of purine nucleotide phosphorylase.
[(A) ribose-1-P; (B)
ribose-5-P; (C) Pi; (D) none of the above]
· Decreased activity of
hypoxanthine-guanine phosphoribosyltransferase will step-wise lead to (#14) _____
synthesis of purine nucleotides.
[(A) increased; (B)
decreased; (C) unaffected]
· The enzymes (A) carbamoyl phosphate synthetase II, (B) aspartate transcarbamoylase, (C) dihydroorotase, (D)
dihydroorotate dehydrogenase, and (E)
orotate phosphoribosyl transferase are involved in the synthesis of orotidine
monophosphate (OMP).
o
For
these five enzymes, an oxidation of substrate to product is catalyzed by the
enzyme (#15) ____.
· The enzyme orotate phosphoribosyl
transferase catalyzes the conversion of a (#16) _____.
[(A) pyrimidine base to the corresponding nucleoside; (B) nucleoside to the corresponding nucleotide;
(C) pyrimidine base directly to the
corresponding nucleotide]
· The N donor for the synthesis of
carbamoyl phosphate by carbamoyl phosphate synthetase II is (#17) ____.
[(A) NH3; (B)
glutamate; (C) the amine (or amino)
group of glutamine; (D) the amide
group of glutamine; (E) aspartate]
· For the pyrimidine as shown below,
the N at position 1 is derived from the (#18) ____.
[(A) amine group of glycine; (B)
amine group of aspartate; (C) amine
group of glutamine, (D) amide group
of glutamine]
· For the synthesis of CTP from
UTP, an extra N is incorporated into the CTP product. This extra N is derived from the (#19) ____.
[(A) amine group of glycine; (B)
amine group of aspartate; (C) amine
group of glutamine, (D) amide group
of glutamine; (E) NH3]
· In animals, carbamoyl phosphate
synthetase II is (#20) ____.
[(A) inhibited by ATP and UTP; (B)
inhibited by ATP but activated by UTP; (C)
inhibited by UTP but activated by ATP; (D)
activated by ATP and UTP; (E) none
of the above]
· In E. coli, aspartate transcarbamoylase is (#21) ____.
[(A) inhibited by ATP and UTP; (B)
inhibited by ATP but activated by UTP; (C)
inhibited by UTP but activated by ATP; (D)
activated by ATP and UTP; (E) none
of the above]
· Nucleotide diphosphate kinase can
convert (#22) ____.
[(A) ribonucleoside diphosphate (NDP) to ribonucleoside triphosphate
(NTP) but cannot convert deoxyribonucleoside diphosphate (dNDP) to
deoxyribonucleoside triphosphate (dNTP); (B)
dNDP to dNTP but cannot convert NDP to NTP; (C) NDP to NTP and also dNDP to dNTP; (D) neither NDP to NTP nor dNDP to d NTP]
· The enzyme thymidylate synthase
catalyzes the conversion of (#23) ____.
[(A) dUMP + N5,N10-Methylene-THF à dTMP + tetrahydrofolate; (B) dUMP + N5,N10-Methylene-THF
à dTMP + dihydrofolate; (C) dUDP + N5,N10-Methylene-THF
à dTDP + tetrahydrofolate; (D) dUDP + N5,N10-Methylene-THF
à dTDP + dihydrofolate]
· In bio-degradation of pyrimidine,
(#24) _____ can be step-wise converted to uracil..
[(A) CMP but not UMP; (B) UMP but not CMP; (C) both CMP and UMP; (D) neither CMP not UMP]
· b-Aminoisobutyrate
is a product from (#25) _____ through a single- or multiple-step of enzymatic degradative
reaction(s).
[(A) dihydrouracil; (B)
dihydrothymine; (C)
β-ureidopropionate; (D) none of
the above]
·
Nitrogen
fixation is the conversion of N2 to 2 NH3. This N2 à 2 NH3 process is
(#26) ____ reaction.
[(A) an oxidative; (B) a reductive; (C)
neither an oxidative nor a reductive]
·
For
the nitrogen fixation reaction catalyzed by nitrogenase, electron transfers
take place in the direction of (#27) ____.
[(A) Fe- protein à MoFe-protein à N2; (B) Mo-Fe-protein à Fe-protein à N2; (C) N2 à Fe- protein à MoFe-protein; (D)
N2 à
Mo-Fe-protein à
Fe-protein; (E) none of the above]
·
The
molecule H2N-NH2 is a (#28) ____. [(A) diimine; (B) hydrazine]
·
In
the nitrogenase-catalyzed nitrogen fixation, hydrolysis of ATP molecules takes
place. As a consequence, the E○’
of the Fe-protein (#29) ____.
[(A) is lowered; (B) is
elevated; (C) remains the same]
[Note: lowered = becomes more negative]
·
In
the nitrogenase-catalyzed nitrogen fixation, the transfer of one electron
requires the hydrolysis of (#30) ____ molecule(s) of ATP.
[(A) 1; (B) 2; (C) 3; (D) 4]
·
α-Ketoglutarate
is (#31) ____ for the mammalian glutamine synthetase.
[(A) an activator; (B) an
inhibitor; (C) neither an activator
nor an inhibitor]
·
For
E. coli, higher concentrations of
glutamine will result in (#32) ____ of glutamine synthetase activity.
[(A) higher levels; (B) lower levels; (C)
no change in the level]
·
For
ammonification, the conversion of one molecule of nitrate to one molecule
nitrite requires (#33) ____ electron(s), and the conversion of one molecule of
nitrite to one molecule of NH3 requires (#34) ____ electrons.
[(A) zero, (B) 1; (C) 2; (D) 4; (E) 6]
·
In
animals, pyruvate (#35) ____.
[(A) can be decarboxylated to acetyl-CoA but cannot be carboxylated
to oxalloacetate; (B) can be
carboxylated to oxalloacetate but cannot be decarboxylated to acetyl-CoA; (C) can be either decarboxylated to
acetyl-CoA or carboxylated to oxalloacetate; (D) cannot be either decarboxylated to acetyl-CoA or carboxylated to
oxalloacetate]
·
Blood
flow is essential to the supply of (#36) ____ to brain.
[(A) glucose but not oxygen; (B)
oxygen but not glucose; (C) both
oxygen and glucose; (D) neither
oxygen nor glucose]
·
The
primary fuel for brain under conditions of extended fast is (#37) ____.
[(A) glucose; (B) glycogen;
(C) fatty acids; (D)
ketone bodies]
·
Muscle
tissue is active in (#38) ____.
[(A) glycolysis but not in gluconeogenesis; (B)
gluconeogenesis but not in glycolysis; (C)
both glycolysis and gluconeogenesis; (A)
neither glycolysis nor gluconeogenesis]
·
When
heart is at a normal resting state, the primary fuel molecule(s) is/are (#39)
____.
[(A) glucose; (B)
glycogen; (C) fatty acids; (D)
ketone bodies]
·
In
adipose tissues, the metabolic fates of fatty acids are (#40) ____ the dihydroxyacetone
phosphate level.
[(A) regulated by; (B)
unrelated to]
·
At
a blood glucose level of ~2 mM in liver, (#41) ____.
[(A) both glucokinase and hexokinase should be operating at levels
close to their respective maximal velocity Vmax; (B) glucokinase should be operating near
its Vmax but hexokinase should be operating at a level substantially
lower than its Vmax; (C) hexokinase
should be operating near its Vmax but glucokinase should be
operating at a level substantially lower than its Vmax; (D) both glucokinase and hexokinase
should be operating at levels substantially lower than their respective Vmax]
·
The
acetyl-CoA generated from fatty acids in liver is used for the synthesis of (#42)
____.
[(A) ketone bodies to be released to peripheral tissues but not for
the synthesis of ATP by TCA and oxidative phosporylation to support the energy
need by liver; (B) ATP by TCA and oxidative
phosporylation to support the energy need by liver but not for the synthesis of
ketone bodies to be released to peripheral tissues; (C) ketone bodies to be released to peripheral tissues and for the
synthesis of ATP byTCA and oxidative phosporylation to support the energy need
by liver; (D) neither ketone bodies
nor ATP]
·
For
the Cori cycle, the energy required for muscle contractions during heavy
exercise is provided primarily through (#43) ____.
[(A) glycolysis and homolactic fermentation; (B) TCA cycle; (C)
oxidative phosphorylation]
·
For
the glucose-alanine cycle, (#44) ____ in liver for gluconeogenesis.
[(A) pyruvate is converted to lactate; (B) lactate is converted to pyruvate]
·
The
adenylate cyclase system involves a trimeric Gs-protein (i.e. sabg)
and also an inhibitory trimeric Gi-protein (i.e. iabg). An GTP hydrolytic activity is associated with
(#45) ____.
[(A) only the sa
but not the ia; (B) only the ia
but not the sa; (C) both the sa
and the ia; (A) neither the sa
nor the ia]
·
In
the absence of cAMP, the cAMP-dependent protein kinase exists as an inactive tetramer
R2C2. Upon binding
by cAMP, the active species of protein kinase is released in the form of (#46)
____.
[(A) an R2 dimer; (B)
2 of R monomers; (C) a C2
dimer; (D) 2 of C monomers]
·
As
a consequence of hormone binding to a usual receptor tyrosine kinase RTK (such
as human growth hormone receptor), RTK undergoes (#47) ____.
[(A) dimerization of RTK but not the cross phosphorylation of the
C-terminal domains; (B) the cross
phosphorylation of the C-terminal domains but not the dimerization of RTK; (C) dimerization of RTK and the
subsequent cross phosphorylation of the C-terminal domains]
·
For
the insulin receptor (αβ)2 dimer, the tyrosine kinase
activity is located in the intracellular portion of β. Following the binding of insulin to the
α subunit, the intracellular portion of the β undergoes (#48) ____.
[(A) both a conformational change and phosphorylation (B)
a conformational change but not any phosphorylation; (C) phosphorylation but not any conformational change; (D)neither any conformational change nor
any phosphorylation]
·
When
the β domain of the insulin receptor is activated to become an active
tyrosine kinase, it (#49) ____ directly bind the SH2-domain of certain cellular
proteins.
[(A) can; (B) cannot]
·
In
the phosphoinositide pathway, the activated membrane-bound phospholipase C catalyzes
the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2) to inositol-1,4,5-triphosphate
(IP3) and 1,2-diacylglycerol (DAG). (#50)
____ lipid-soluble second messenger.
[(A) Both IP3 and DAG are; (B)
IP3 is but DAG is not; (C) DAG is
but IP3 is not; (D) Neither IP3 nor
DAG is]
Answers: (1-D), (2-C), (3-D), (4-A), (5-C), (6-B), (7-D), (8-A), (9-D), (10-D), (11-A), (12-D), (13-A), (14-A), (15-D), (16-C), (17-D), (18-B), (19-D), (20-C), (21-E), (22-C), (23-B), (24-C), (25-B), (26-B), (27-A), (28-B), (29-A), (30-B), (31-A), (32-B), (33-C), (34-E), (35-C), (36-C), (37-D), (38-A), (39-C), (40-A), (41-C), (42-C), (43-A), (44-B), (45-C), (46-D), (47-C), (48-A), (49-B), (50-C)